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Abstract 
Background: Urinary tract candidiasis is known as the most frequent nosocomial fungal infection worldwide. 
Some of the predisposing factors of candiduria are extensive use of broad-spectrum anti-fungal agents, diabetes 
mellitus, indwelling urinary catheter, corticosteroids and, immunosuppressive drugs. There are some antifungal 
agents available for the treatment of candiduria. In recent years, resistance to antifungal agents has been 
increased. The aim of this study was to evaluate different Candida species (sp.) that cause candiduria and their 
susceptibility pattern to antifungal agents in patients admitted to educational hospitals. 
Materials and Methods: Urine samples (n=200) were obtained; they were spread onto Sabouraud Dextrose Agar 
plates. Plates were incubated at 37°C. Only specimens were considered as candiduria, which have a colony count 
of ≥104 CFU/mL colonies. Urine sediment was cultured in the CHROM agar Candida medium and incubated at 
35°C for 48h. The cultures were evaluated based on color. PCR-RFLP was performed for a definite identification 
of Candida sp. In vitro antifungal susceptibility test of the Candida isolates against amphotericin B, fluconazole 
and itraconazole was performed using the microdilution method, according to the standard CLSI guidelines, 
document M27-S3. 
Results: Molecular findings confirmed the result of the morphological method. Candiduria rate was 11.5% 
among our patients. According to CHROM agar Candida and PCR-RFLP, the most common species isolated 
was C. albicans (74%), followed by C. glabrata (26%). In vitro susceptibility tests of urinary Candida isolates 
to antifungals have been evaluated. All species were sensitive to amphotericin B. None of C. glabrata isolates 
were sensitive to fluconazole and itraconazole. 
Conclusion: This study demonstrates the importance of Candida sp. in urine samples from hospitalized patients. 
It was concluded that Candida sp. obtained from candiduria in patients had excellent activity against 
Amphotericin B. Whereas, resistance against Itraconazole (21.7%) and especially Fluconazole (26%) was 
significant. 
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Introduction 
Among microorganisms that cause urinary tract 
infection (UTI), fungi are responsible for 10% of these 
infections1. The incidence of UTI has increased in 
recent years due to extensive use of broad-spectrum 
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anti-microbial agents, corticosteroids, 
immunosuppressive and cytotoxic drugs2. In addition, 
elderly age, diabetes mellitus and indwelling urinary 
catheter are some of UTI risk factors3. 
The majority of fungal infections of the urinary tract 
caused by Candida species (sp.)4. Although several 
species of Candida (especially, C. albicans) are 
normal flora of the skin and the gastrointestinal and 
genitourinary and respiratory tracts5. 
Candiduria is a general term for the presence of 
Candida sp. in urine. Candiduria may be related to 
colonization of Candida sp. in urinary tract. Also, 
invasive infections such as pyelonephritis/cystitis or 
disseminated candidiasis can cause candiduria2. 
In addition, candiduria was defined as the presence of 
Candida >104 CFU/mL (colony forming unit/mL of 
urine). Totally in Iran, the most common etiologic 
agents of candiduria are C. albicans, C. glabrata, C. 
tropicalis, C. krusei, C. parapsilosis, C. kefyr and C. 
lusitaniae5. 
The aim of this study was to evaluate different 
Candida sp. that cause candiduria in hospitalized 
patients, identify isolated Candida sp. (morphological 
and molecular) and their susceptibilities to antifungal 
agents. 
Methods 
This cross-sectional study was conducted from 
February 2018-April 2019 on 200 hospitalized 
patients with raging 15-80 years admitted to 
educational hospitals affiliated to Shahid Beheshti 
University of Medical Sciences (SBUMS), Tehran, 
Iran. The Ethical Committee of Shahid Beheshti 
University of Medical Sciences approved this study 
under the code: IR.SBMU.RETECH.REC.1396.342. 
In this study, to examine patients regarding 
candiduria, about 10 mL of urine samples were 
obtained in sterile urine bottles. The urine samples 
were spread by the calibrated loop (0.01 mL) onto 
Sabouraud Dextrose Agar (SDA; Merck, Germany) 
plates. These plates were supplemented with 
100μg/mL of chloramphenicol (Merck, Germany) for 
colony count. Plates were incubated at 37°C and read 
them 24 hours later. In this survey, the detection level 
for quantitative cultures was 100 CFU/mL (colony-
forming unit/mL), represented by a single colony of 
yeast on a plate6. 
After the incubation period, the number of the Candida 
colonies was counted and only specimens were 
considered as candiduria, which have a colony count of 
≥104 CFU/mL colonies. The prepared suspension of 
urine sample was examined by direct microscopic 
examination after centrifugation (3000 rpm/3min). 
Then, 20μl of the suspension was cultured on CHROM 
agar Candida medium (bioMérieux, France). The 
culture media were incubated at 35°C for 48h and 
evaluated based on color. For each patient, the 
following data was recorded from the patient’s profile: 
sex, age, antifungal therapy, underlying disease 
(Diabetes mellitus, malignancy, urinary catheter, 
steroid, and antimicrobial agents use), and duration of 
stay in the hospital. 
Antifungal susceptibility testing: In vitro antifungal 
susceptibility test of the Candida isolates against some 
antifungals such as amphotericin B (AMB) (Sigma-
Aldrich, USA.), fluconazole (FLU) (Sigma-Aldrich, 
USA.), and itraconazole (ITR) (Sigma-Aldrich, USA.) 
was performed. These tests were made using the 
microdilution method, according to the clinical and 
laboratory standards institute (CLSI, document M27-
S3) guideline7. 
Reagent grade powder of FLU, ITR and AMB were 
obtained from their respective manufacturers. Stock 
solutions were prepared in water (for fluconazole) or 
dimethyl sulfoxide (DMSO) (for amphotericin B and 
itraconazole). Dilution of antifungal drugs was  
performed with RPMI 1640 medium (Invitrogen, USA) 
and buffered to pH 7.0 with 0.165M morpholine 
propane sulfonic acid buffer (MOPS) as described 
previously (Sigma, USA). The assay was conducted in 
96-well round-bottom micro-titer plates. Cell 
suspensions were prepared in RPMI and were adjusted 
to give a final inoculum concentration of about 0.5×103-
2.5×103 cells/mL. Then the plates were incubated at 
35°C and read after 48 h. Then the minimum inhibitory 
concentrations (MICs) were determined and compared 
with a drug-free control. All tests were performed two 
times. Quality control isolates, Candida parapsilosis 
(ATCC 22019) were included in all runs8. MIC against 
AMB was ≤1μg/mL, which is considered as susceptible 
and >1μg/mL as resistant. In addition, regarding ITC, 
MICs ≤ 0.125 and ≥1μg/mL and for FLU, MICs ≤ 2 and 
≥ 8μg/mL were considered as susceptible and resistant, 
respectively. 
Candiduria: Prevalence, Identification of Isolated Candida Species and Trends ….                                       Ghasemi et al. 
NBM 73 Novelty in Biomedicine 2020, 2, 71-8 
PCR-RFLP: All isolated strains sub cultured on 
Sabouraud Dextrose Agar medium (SDA; Merck, 
Germany) and genomic DNA were extracted using the 
phenol-chloroform method. Briefly, yeast cells were 
harvested and lysed adding 0.3g of glass beads 
(diameter, 0.45 to 0.52mm; Sigma, St. Louis, MO), 
300μl of DNA lysis buffer (100mM Tris-HCl, pH 8.0, 
2% Triton X-100, 1% sodium dodecyl sulfate, 1mM 
EDTA), and 300 μl of phenol-chloroform-isoamyl 
alcohol (PCI) (25:24:1). The mixture was then 
vortexed for 30 sec and centrifuged at 5,000 rpm for 
five minutes. The supernatant was collected, 300μl of 
chloroform was added, and vortexed for few seconds 
and centrifuged again; then 250μl of ethanol and 25μl 
of 3M sodium acetate (pH 5.2) were added to the 
obtained supernatant and incubated for 10 minutes at 
-20°C. The mixture was then centrifuged at 12,000 
rpm for 12 minutes and the pellet was re-suspended in 
100μl distilled water as purified DNA and stored at -
20 °C until used9,10. 
PCR-RFLP was performed for a definite identification 
of species as described previously9,10. Briefly, PCR 
amplification was performed using the universal 
primers ITS1 (forward: 5ʹ-
TCCGTAGGTGAACCTGCGG-3ʹ) and ITS4 
(reverse: 5ʹ-TCCTCCGCTTATTGATATGC-3ʹ). 
PCR products were digested by MspI restriction 
enzyme and restriction fragments were separated by 
1.8% agarose gel electrophoresis. 
Statistical analysis: Statistical analyses were 
performed using SPSS software version 16.0. The 
findings were informed using descriptive statistics 
such as mean and standard deviation or frequency and 
percentage. 
Results 
Of the 200 urine samples, in the culture, 23 (11.5%) 
patients were yielded Candida sp. (19 urine samples 
from ICUs and 4 from other wards). They had a 
significant candiduria with a colony count of ≥104 
CFU/mL, however, no bacterial growth was present. 
The colony count was different from 104 to ≥106 
CFU/mL. It was present in 9 (39%) out of 88 male and 
14 (61%) out of 112 female patients. The highest 
isolation rates of Candida sp. were found in age group 
between 41-60 years (Table 1). The mean age of the 
study population was 42.7±10.2 years (range 15–80 
years). 
None of the patients received antifungal drugs for 
prophylaxis or treatment. The length of hospitalization 
before candiduria was higher than seven days for 83% 
(19/23) of the patients.  
Underlying conditions in patients (n=23, 100%) were 
include: diabetes mellitus (n=21, 91%), urinary catheter 
(n=18, 78%), steroid and antibiotic use (n=11, 48%), 
and malignancy (n=8, 34%). The most common risk 
 
Figure 1. Budding yeast cells, pseudohyphae and true mycelium of 
Candida albicans (A), and Budding, small yeast cells of Candida 
glabrata (B), in direct examination of urine sediment (×400). 
 
 
Figure 2. Colonies of Candida sp. isolated from urine culture 
on CHROM agar Candida. (A) Light green colonies of Candida 
albicans. (B) cream to white colonies of Candida glabrata. 
 
 
Figure 3. RFLP-PCR products of Candida sp after digestion 
with the enzyme MspI. Lane M is 100bp DNA size marker, 
Lane1 (1, 2, 4, 6) are C. glabrata  (314 and 557 bp), Lane3 is C. 
albicans  (238 and 297bp), Lane5 is C. albicans (ATCC 12261). 
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factors were diabetes mellitus (91%). 
Direct examination showed ovoid shaped yeast cells, 
budding cells (3-15μm), pseudohyphae and true 
mycelium in the sediment of the urine (Figure 1). 
The colonies were recognized based on the color of 
the colonies produced by the Candida sp. on the 
CHROMagar Candida incubated at 35 °C for 48h. 
Light green colonies were C. albicans and cream to 
white colonies were C. glabrata (Figure 2)11. 
Using PCR-RFLP method, the most common species 
isolated was C. albicans (n = 17, 74%), followed by 
C. glabrata (n = 6, 26%) (Table 2). Molecular findings 
confirmed the result of morphological method. 
 
MIC ranges, MIC50/MIC90 values of antifungal 
agents for urinary Candida isolates are shown 
in Table 2. 
Discussion 
Candiduria is explained as the presence of more than 
104 CFU/mL of the Candida sp. in the urinary system 
with different forms, asymptomatic form to clinical 
sepsis. This study had evaluated candiduria among 200 
hospitalized patients admitted to educational hospitals 
of Shahid Beheshti University of Medical Sciences 
(SBUMS).To the best of our knowledge, this was the 
first report on evaluation the antifungal susceptibility 
pattern of Candida sp. isolated from urine against 
AMB, FLU, ITC by CLSI guideline. In Iran, there are 
only two studies on susceptibility pattern of Candida 
species obtained from patients with candiduria using 
other methods12,13.  
Epidemiological studies in Iran showed that the mean 
prevalence of candiduria was around 16.5%.  
Table 1: Age and Gender distribution of Candida isolates. 
Age group 
(year) 
1-20 21-40 41-60 >60 Total 
Male 1 2 4 2 9 (39%) 
Female 1 4 7 2 14 (61%) 
Total 2 6 11 4 23 (100) 
 
 
Table 2: In vitro susceptibilities of urinary Candida isolates to fluconazole, Itraconazole and amphotericin B. 












(24 h) (μg/mL) 
C. albicans 
(17) 
FLU 13 2 2 0.125-32 1/16 
 
ITC 7 8 2 0.0625-2 0.5/2 
 
AMB 17 - - 0.25-0.5 0.25/0.5 
C. glabrata 
(6) 
FLU - 2 4 4-32 16/32 
 ITC - 3 3 0.25-0.5 0.5/2 
 AMB 6 - - 0.25-0.5 0.5/0.5 
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The highest was in Qazvin (32.3%) and lowest in 
Khuzestan (5.2%) provineces5,14. Our finding showed 
candiduria in women (61%) was more than men 
(39%). This difference may be caused by the 
anatomical status of the urinary system in women, 
vaginal infections and its proximity to anus15. Our 
results support similar studies conducted in Iran that 
showed a higher rate of candiduria among females 
than males12,15-19. Although some studies indicated 
higher rate among males5,20-22. 
The most common predisposing factor among patients 
was diabetes mellitus (91%) followed by urinary 
catheters (78%). Because of the glycosuria caused by 
diabetes, urinary yeast growth increases. 
Consequently, diabetes may influence women by 
candiduria due to Candida colonization of the 
vulvovestibular zone23.  
The use of prolonged urinary catheters has been 
studied to be significant risk factors for candiduria. 
The colony counts more than 105 CFU/mL, are usually 
associated with prolonged urinary catheters24.  
Another risk factor was steroid and antibiotic use. It 
seems that prolonged antibiotic use 
facilitates colonization by Candida sp. and this 
contribution may suppress endogenous bacterial flora1. 
The effect of the use of steroid and antibiotic has been 
documented in the literature25,26. 
In the present study, C. albicans was the most common 
(74%) isolated species from urine samples followed by 
C. glabrata (26%). In similar studies reported in Iran, 
C.albicans was the most common cause of candiduria 
among all Candida sp.12,13,15,16,18,20-22. Whereas, some 
other studies were performed in Iran, identify C. 
glabrata as the most common cause of candiduria 
among patients17,19. 
Recently, Candida non-albicans was highly dominant 
in the urine, this tendency 
probably relates to the complex chemical composition 
of the urine (like pH)26. 
Candiduria may refer to colonization and does not need 
treatment, also UTI can lead to renal candidiasis and 
pyelonephritis 4. 
The first step is the diagnosis of candidal UTI. 
Urine contamination or infection of the sample can be 
a problem. There is no standard definition for detecting 
candidal UTIs directly; therefore, the first positive urine 
culture was repeated to document an accuracy of 
results. UTI patients are 
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classified as either asymptomatic or symptomatic cas
es.  
In the case of symptomatic, antibiotic treatment was 
administered parallel with an antifungal drug like 
FLU. Symptomatic candiduria is seen in patients with 
cystitis, epididymorchitis, prostatitis, pyelonephritis, 
and renal candidiasis. For this reason, 
systemic treatment with antifungals is recommended 
in high-risk patients. However, the majority of people 
with candiduria are asymptomatic27-29. In this survey, 
asymptomatic candiduria is seen in all of the patients 
(n=23). Some studies have indicated that the mortality 
rate among candiduric patients was reported about 
26% and candiduria among the critical patients can be 
a sign of disseminated infection, especially 
candidemia. Candidemia occurred among patients 
with asymptomatic candiduria in several studies1,6,30. 
In recent years, the prevalence of candiduria has 
increased among hospitalized patients. Due to the 
extensive use of antifungal agents in hospitals, 
resistant fungal strains have become a challenge for 
clinicians. In our study, we survey the susceptibility 
of C. albicans and C. glabrata to FLU, ITC and AMB. 
Due to safety, the pharmacokinetic and 
pharmacodynamic profile of FLU, it is a common 
choice for treatment of Candida UTIs13,31,32.  
AMB is another choice for Candiduria which is 
recommended only for infection is caused by FLU-
resistant strains33. Due to the toxicity of AMB, 
consumption is limited for all clinical forms of 
candiduria34,35. In addition, ITC is antifungal 
medications used for a variety of fungal infections. 
We found that FLU and ITC resistance rates of C. 
albicans were 11.7%. All Candida sp. were sensitive 
to AMB. Zarei et al. reported that the most number of 
C. albicans  were resistant to FLU and completely 
susceptible to ITC and AMB13. 
C. glabrata infections are often resistant to many 
azole antifungal agents, especially FLU; therefore, 
this infection is difficult to treat. Some similar works 
indicated that, compared to other Candida sp. 
(especially C. albicans) C. glabrata isolates tend to be 
associated with higher MICs of all azoles and are 
innately less susceptible to all antifungal agents 
including AMB36,37. 
In our study, relatively high levels of resistance to 
azole (58%) were found in isolates of C. 
glabrata. This species may be intrinsically resistant to 
FLU, thus urinary tract infections caused by C. glabrata 
are the most difficult to treat. Research has 
also demonstrated that different outcomes with C. 
glabrata may reflect the high doses of and prolonged 
therapy with FLU. It is suggested that susceptibility 
testing should be performed in this situation. 
The result of our susceptibility test showed that none of 
C. glabrata species were sensitive to FLU and ITC. 
Interestingly, all C. glabrata were sensitive to AMB. In 
contrast to Zarei et al. that found 64% of this species 
were not sensitive to AMB. They reported that 
resistance rate of C. glabrata to ITC was 0%20. The 
increase of C. glabrata, due to the resistance to azoles 
brings up the importance of typing of all Candida sp. 
recovered in urine from patients. 
Conclusion 
Our observations indicate that candiduria prevalence 
was 11.5% among patients. The most common species 
isolated from urine samples was C. albicans followed 
by C. glabrata. Although, studies 
have been conducted on candiduria in the world, but 
there have been some articles on this issue in Iran 
(Table 3).  
Further studies on a much larger scale 
needed to provide more information on various 
Candida sp. causing urinary tract infection and their 
antifungal susceptibility pattern in this region. Hence, 
information that is more comprehensive will help in an 
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